503B Pharmacy

An outsourcing facility registered with the FDA that can produce larger quantities of compounded drugs without individual prescriptions, subject to cGMP standards. Generally produces hospital and clinic supplies.

What does 503B Pharmacy mean in peptide research?

An outsourcing facility registered with the FDA that can produce larger quantities of compounded drugs without individual prescriptions, subject to cGMP standards. Generally produces hospital and clinic supplies. This term is part of the broader field of peptide research, which encompasses both FDA-approved therapeutic peptides and research-grade compounds used in scientific investigation.

Why this term matters

Understanding 503B Pharmacy is foundational for anyone reviewing peptide research literature, comparing different research compounds, or following regulatory developments in this field. The term appears across pharmacology textbooks, FDA documentation, and clinical trial reports.

Where to learn more

For deeper context, see our peptide research articles:

• What Are Peptides? Comprehensive Introduction
• Research-grade vs Clinical-grade Peptides
• FDA Peptide Regulatory Status 2026
• Full Peptide Glossary Article